QR kód

Anti-spike antibody responses to SARS-CoV-2 mRNA vaccines in people with schizophrenia and schizoaffective disorder

Importance: Individuals with schizophrenia are at higher risk for severe COVID-19 illness and severe breakthrough infection following vaccination. It is unclear whether immune response to vaccination differs in this population. Objective: To assess whether anti-SARS-CoV-2 spike antibody titers after...

Celý popis

Uloženo v:
Hlavní autoři: Katlyn Nemani, Livia De Picker, Faith Dickerson, Marion Leboyer, Michele Santacatterina, Fumika Ando, Gillian Capichioni, Thomas E. Smith, Jamie Kammer, Kawtar El Abdellati, Manuel Morrens, Violette Coppens, Emily Katsafanas, Andrea Origoni, Sabahat Khan, Kelly Rowe, R.Sarah Ziemann, Ryad Tamouza, Robert H. Yolken, Donald C. Goff
Médium: Artigo
Jazyk:Inglês
Vydáno: Elsevier 2024-07-01
Edice:Brain, Behavior, & Immunity - Health
Témata:
Schizophrenia
Schizoaffective disorder
COVID-19
mRNA vaccine
Immunogenicity
Antibody response
On-line přístup:http://www.sciencedirect.com/science/article/pii/S2666354624000802
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Podobné jednotky